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ABSTRACT
Sepsis is a leading cause of preventable maternal mortality in developing countries due to poverty, home 
deliveries by untrained persons in unhygienic conditions, limited access to healthcare facilities and lack 
of availability of antibiotics. Recent confidential enquiries into maternal deaths from the developed 
nations have revealed an increase in maternal mortality secondary to genital tract sepsis and provision of 
suboptimal critical care. Early recognition of critical illness in obstetric patients, involvement of intensive 
care teams earlier and provision of same standard of critical care to pregnant women as non-pregnant 
patients while being mindful of the altered maternal physiology and fetal wellbeing is necessary to 
improve outcome of this vulnerable population.
This article reviews the definitions and risk factors of maternal sepsis and describes the standards 
recommended for efficient delivery of maternal critical care and sepsis management.                                                        
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INTRODUCTION
Sepsis is responsible for causing more deaths 
globally than prostate cancer, breast cancer and HIV/
AIDS combined1 and is the one of the most common 
causes of mortality in the intensive care units.2 In 
the developing world, 60-80% of childhood deaths 
are due to sepsis resulting in the death of over 6 
million newborns and children every year along 
with over 100,000 cases of maternal sepsis3 The 8th 
report of The Confidential Enquiry into Maternal 
Deaths (CEMCH) published in March 2011 showed 
a decrease in the overall maternal mortality rate in 
UK from13.95 to 11.39 per 100,000 deliveries but 
the report indicated an increase in deaths related to 
genital tract infections and sepsis was rated as the 
most common cause of direct maternal death.4
Admission rate of obstetric patients to general or 
surgical critical care units varies from 0.05-1.7% of 
total admissions in developed countries5 to about 
11.6% in developing countries.6 Recent ICNARC 
(Intensive Care National Audit and Research Centre) 
Case Mix Programme (CMP) data showed that 11.4% 
of women between the age of 16 years and 50 years 
who were admitted to adult general intensive care 
units in England, Wales and Northern Ireland were 
either pregnant or recently pregnant.7 Critically ill 
obstetric patients present a unique challenge to 
the intensivists due to altered maternal physiology 
and concerns regarding fetal safety and outcome. 
Early recognition of critical illness, involvement of 
intensive care teams earlier and provision of same 
standard of critical care to pregnant women as non-
pregnant patients is necessary to improve survival 
of critically ill women in the peripartum period.8
The objective of this article is to review the definitions 
and underlying causes of maternal sepsis which is a 
re-emerging threat to maternal health and describe 
the standards recommended for efficient delivery 
of maternal critical care and sepsis management.
DEFINING MATERNAL SEPSIS
Globally 10% of maternal deaths are caused by 
sepsis, and the incidence is highest in Southeast Asia 
(13.2%) and Africa (10%) 9. However, describing the 
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total burden of maternal sepsis is challenging for a 
number of reasons. Firstly there is a lack of a uniform 
definition of maternal sepsis. Secondly there is 
confusion whether to include maternal deaths 
resulting from genital tract sepsis only or to include 
maternal deaths resulting from all other sources of 
infection like urinary tract infections, respiratory 
tract infections, mastitis, malaria, hepatitis, dengue 
fever, HIV, and nosocomial infections.10,11 Thirdly 
there is gross underreporting of sepsis and 
maternal deaths in the developing countries where 
the burden of disease is the greatest due to lack of 
data of home deliveries and absence of postnatal 
follow-up after hospital discharge.12
Another reason ismisclassification of the cause of 
the maternal deaths as ‘indirect cause’ instead of 
sepsis being the ‘direct cause’ of maternal death in 
countries where endemic diseases like HIV, malaria 
and tuberculosis are highly prevalent or in the 
presence of significant comorbid diseases.13
World Health Organization (WHO) defines 
Puerperal Sepsis as, “infection of the genital 
tract occurring at any time between the onset of 
rupture of membranes or labour and the 42nd 
day postpartum in which fever and one or more of 
the following are present: pelvic pain, abnormal 
vaginal discharge, abnormal smell/foul odour of 
discharge and delay in the rate of reduction of the 
size of the uterus”.14
International Classification of Diseases (ICD-10) 
defines ‘Puerperal Sepsis’ as, “temperature rise 
above 38.08ºC (100.48ºF) maintained over 24 hrs 
or recurring during the period from the end of the 
first to the end of the 10th day after childbirth or 
abortion”. 
American College of Chest Physicians and the 
Society of Critical Care Medicine attempted to 
standardize definitions15 for systemic inflammatory 
response syndrome (SIRS), sepsis, severe sepsis 
and septic shock in 1992 (Table 1) which were later 
elaborated at an international sepsis definition 
conference in 2001.16 Onset of labour and rupture 
of membranes triggers symptoms of SIRS even 
without the presence of an infection and may mask 
a serious infection.
RISK FACTORS OF SEPSIS DURING 
PREGNANCY
Pregnant women are highly susceptible to 
infection because the maternal immune response 
is down-regulated to protect the immunologically 
distinct foetus17 and there is loss of the protective 
physiological barriers against bacterial infection 
with the onset of labour.11
The surgical site and the endometrium is exposed 
to pathogens during Cesarean section, increasing 
the risk of severe infections five to 20-fold in women 
who undergo operative delivery as compared 
to women who deliver naturally.18 Increased 
incidence of caesarian sections and obesity are two 
most important factors contributing to increased 
maternal mortality due to sepsis in UK.19
Poverty, home deliveries by untrained persons in 
unhygienic conditions, limited access to healthcare 
facilities and lack of availability of antibiotics are 
the most important factors that increase the risk 
of maternal sepsis in developing countries.20 HIV-
related infections are the main cause of maternal 
mortality in sub-Saharan and southern Africa.21
Table 1: Definitions related to sepsis [15]
SIRS Sepsis Severe Sepsis Septic shock
Two of the following
Heart rate ≥ 90 bpm • 
Respiratory rate • 
≥ 20 bpm or PaCO2 < 32 
mmHg
Temperature • 
≥ 38°C or ≤ 36°C 
WBC ≥12000 or ≤ • 
4000 cells/µL or ≥10% 
immature forms
SIRS with a suspected or 
documented 
source of infection 
Sepsis associated with organ 
dysfunction i.e.
Decreased GCS• 
Decreased urine output • 
<0.5ml/kg/hr for > 2 hrs
Creatinine > 2 mg/dl• 
Bilirubin > 2 mg/dl• 
INR >1.5• 
Acute Lung Injury with PaO• 2/
FiO2 <300
Plasma C-reactive Protein>2 • 
SD above normal
Serum Lactate > 4 mmol/L• 
Organ dysfunction despite 
adequate fluid resuscitation
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Table 2: Risk factors for severe maternal morbidity and 
mortality from sepsis [13]
High income countries Low income countries
Cesarean section
Emergency Cesarean section
Prolonged rupture of membranes
Retained products of conception
Early labour
Multiple vaginal examinations (>5)
Obesity
Diabetes
Anemia
Low socioeconomic status
Winter months
Failure to recognize severity
Poverty
Unhygienic birth conditions
Lack of skilled birth assistants
Long distance to healthcare facility
Unavailable medical supplies
Young age
Primiparity
Anemia
HIV, Tuberculosis, Malaria
Failure to recognize severity
Invasive streptococcal infections are responsible 
for most cases of severe sepsis world over.22, 23 
Hypervirulent strains of gram-positive Streptococcus 
pyogenes or group A streptococcus (GAS) were 
responsible for 45% of direct maternal deaths from 
genital tract sepsis in the UK in the triennium 2006-
2008.4 GAS resides in the human nasopharynx and 
is transmitted during influenza outbreaks via the 
respiratory tract or the perineum gets contaminated 
directly when proper hand hygiene is not observed 
resulting in genital tract infection.24
IMPACT OF CARDIORESPIRATORY 
CHANGES OF PREGNANCY ON 
MATERNAL CRITICAL CARE
Physiological changes of pregnancy help adapt the 
mother to the requirements of the foetus and the 
placenta. The hormone progesterone is a potent 
smooth-muscle relaxant and respiratory stimulant 
and is responsible for most of these maternal 
adaptations that return to normal approximately 
6 weeks after delivery.25 These cardiorespiratory 
adaptations of pregnancy have a significant impact 
on critical care management of the mother.
Blood volume increases progressively by up to 
50%, so the mother can lose up to 30% of her 
blood volume before her vital signs change. In the 
event of significant maternal hypotension, placenta 
experiences vasoconstriction unlike other vital 
organs resulting in placental hypoperfusion, fetal 
hypoxia and acidosis. Fetal distress may be the first 
sign of maternal haemodynamic instability. Maternal 
systolic blood pressure should be maintained at 90 
mmHg to ensure adequate placental perfusion, 
however the haemodynamic targets should be re-
set in view of the altered physiological variables,26 
as shown in Table 3. After 20 weeks gestation the 
gravid uterus can cause aortocaval compression, 
decreasing uterine perfusion and venous return to 
the heart. Ensuring adequate lateral maternal tilt 
or manual displacement of the uterus are simple 
but effective maneuvers to prevent aortocaval 
compression and the resulting hypotension.
Table 3: Changes in physiological variables during late 
pregnancy (Clinical Physiology in Obstetrics, 3rd edn. Oxford: 
Blackwell Science;1998)
Parameter Value change
Systolic arterial pressure
Mean arterial pressure
Diastolic arterial pressure
Central venous pressure
Pulmonary capillary wedge 
pressure
Heart rate
Stroke volume
Cardiac output
Systemic vascular resistance
- 5 mmHg
-15 mmHg
-15 mmHg
No change
No change
+15%
+30%
+45%
-15%
Tidal volume
Respiratory rate
Minute volume
Oxygen consumption
+40%
+10%
+50%
+20%
pH
PaO2
PaCO2
HCO3
No change
+10 mmHg
-10 mmHg
-4 mmol/l
Total blood volume
Haematocrit
Plasma albumin
Oncotic pressure
+40%
-0.06
-5 g/l
-3 mmHg
As the uterus expands out of the pelvis during 
pregnancy, the diaphragm elevates limiting the 
lung expansion. Residual volume and functional 
residual capacity are reduced resulting in decreased 
reserve when respiratory decompensation occurs. 
Tidal volume, minute ventilation and oxygen 
consumption increase to cope with the increased 
metabolic demands. Maintaining a maternal PaO2 
> 60 mmHg will help ensure adequate foetal 
oxygenation. Although changes in anatomy and 
lung compliance don’t make mechanical ventilation 
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difficult in pregnant women, the lung protective 
strategies recommended for managing adult 
respiratory distress syndrome (ARDS) may be more 
difficult to implement.27 Low tidal volumes make 
it difficult to maintain the increased ventilatory 
demands of pregnancy and higher tidal volumes 
and alveolar plateau pressures up to 35 cm H2O 
may be necessary. Permissive hypercapnoea may 
cause fetal respiratory acidosis that will reduce the 
ability of foetal haemoglobin to bind oxygen. Prone 
positioning recommended for severe ARDS has not 
been investigated during pregnancy. Upper airway 
oedema makes the airway management potentially 
difficult and delayed gastric emptying increases the 
risk of pulmonary aspiration 
DRUG SAFETY IN PREGNANCY
Vasopressors cause vasoconstriction in all 
vessels therefore while selecting a vasopressor 
it is important to select an agent that preserves 
uteroplacental perfusion. However vasopressors 
have diverse effects on fetoplacental circulation and 
the underlying pharmacodynamic mechanisms and 
their clinical implications are unclear.28 Ephedrine 
crosses the placenta and may cause fetal tachycardia 
and acidosis. It should only be used as a bolus 
agent for short-lived hypotension. Phenylephrine 
may cause more uteroplacental vasoconstriction 
but is associated with less fetal acidosis, better 
neonatal outcomes and is more suitable when 
continuous infusions are indicated.29 Dopamine is 
commonly used in pregnant women with sepsis, 
although both dopamine and dobutamine decrease 
uterine blood flow. Vasopressin may cause uterine 
contractions so it should be used cautiously in the 
third trimester. Epinephrine and norepinephrine 
can also cause vasoconstriction of the maternal and 
placental vasculature especially in hypoxic women 
and are best avoided.25
Opioids, benzodiazepines, propofol and 
barbiturates are relatively safe in pregnancy, even 
though they easily cross the placenta. The newborn 
may experience withdrawal effects if any of these 
therapies have been used for more than a few 
hours before delivery but infusions of these agents 
in an intensive care setting are justified even if the 
women delivers while still receiving them. These 
agents also cross into breast milk and may cause 
considerable sedation in newborns, especially 
those born prematurely. Fentanyl may be a better 
choice of opioid because oral absorption is low but 
high-dose infusions could still cause respiratory 
depression in the newborn.25
LEVELS OF MATERNAL CRITICAL CARE
Four levels of care are recommended for pregnant 
or recently pregnant woman,30 depending on the 
organ support and level of monitoring required, 
and independent of the diagnosis. 
Level 0 or normal ward care: 
• For the care of low risk woman.
Level 1 or additional monitoring or step down from 
higher level of care:
• Neuraxial analgesia
• Risk of haemorrhage
• Oxytocin infusion
• Remifentanil infusion
• Mild pre-eclampsia on oral anti-hypertensives/
fluid restriction 
• Chronic medical condition at risk of deterioration 
such as congenital heart disease or diabetes 
requiring insulin infusion. 
Level 2 or single organ support:
Basic Respiratory Support (BRS)
• 50% or more oxygen via face-mask to maintain 
oxygen saturation
• Non-invasive ventilation (CPAP or BiPAP)
Basic Cardiovascular Support (BCVS)
• Infusion of anti-hypertensives (labetalol or 
hydralazine) to control blood pressure in pre-
eclampsia
• Arterial line used for pressure monitoring or 
sampling
• CVP line used for fluid management and CVP 
monitoring to guide therapy
Advanced Cardiovascular Support (ACVS)
• Simultaneous use of at least two intravenous, anti-
arrhythmic/antihypertensive/vasoactive drugs
• Need to measure and treat cardiac output
Neurological Support
• Magnesium infusion to control seizures (not 
prophylaxis)
Hepatic support
Acute fulminant hepatic failure, e.g. from 
HELLP syndrome or acute fatty liver, such that 
transplantation is being considered
Level 3 or advanced respiratory support alone or 
support of 2 or more organ systems as above
440 ANAESTH, PAIN & INTENSIVE CARE; VOL 18(4) OCT-DEC 2014
Management of maternal sepsis
Advanced Respiratory Support
• Invasive mechanical ventilation
Support of two or more organ systems
• Support of two or more organ systems-Renal 
support and BRS; BRS/BCVS and an additional 
organ supported
FETAL MONITORING IN INTENSIVE 
CARE UNIT
Organ support and multiple drugs required by the 
mother during critical illness may adversely affect 
the fetal wellbeing. In order to ensure adequate 
placental perfusion and oxygenation and avoid 
premature labour it is important to monitor the 
fetus in the intensive care unit along with the 
maternal monitoring.
1. ULTRASOUND
 Abdominal ultra sound is a non-invasive 
technique that is widely available in the 
intensive care units. It helps assess
• Fetal viability and position.
• Placenta location and abruption status.
• Amniotic fluid volume.
• Uterine artery blood flow.
2. CTG MONITORING
 Cardiotocography (CTG) or electronic foetal 
monitoring (EFM) is a technique for assessing 
fetal wellbeing during labour. Following 
standard terminologies are used to interpret a 
CTG trace.31
• Baseline foetal heart rate (FHR) is determined 
over a period of 5-10 minutes and is 110-160 
beats per minute (bpm).
• Baseline variability is the minor fluctuation 
in baseline FHR (6-25 bpm) assessed in one 
minute segments of the trace. 
• Accelerations are transient increases in FHR 
of 15 bpm or more above the baseline and 
lasting 15 seconds.
• Decelerations are transient episodes of 
decrease of FHR below the baseline of more 
than 15 bpm lasting at least 15 seconds. 
Decelerations indicate an abnormal CTG. Late 
decelerations are a sign of utero-placental 
insufficiency and warrant prompt attention.
 Close collaboration between intensivists and 
the obstetricians is required for interpretation 
and clinical management response to an 
abnormal CTG.
CURRENT RECOMMENDATION FOR 
SEPSIS MANAGEMENT
Management of pregnant patients in sepsis is not 
different from the management of other septic 
patients as long as the altered maternal physiology 
and wellbeing of the fetus are considered. The 
normal physiological adaptations seen in pregnancy 
make early detection of sepsis difficult on one 
hand and may exacerbate the organ dysfunction 
associated with sepsis on the other hand. Use of 
modified early obstetric warning score (MEOWS) 
leads to timely recognition of an obstetric patient 
becoming critically ill32 and The Royal College of 
Obstetrics and Gynaecology33 endorses the use of 
evidence-based recommendations of the Surviving 
Sepsis Campaign (SSC) to manage severe maternal 
sepsis. 
Following are the treatment and intervention 
bundles for early goal directed therapy [34]. 
Initiate the following after recognition of severe 
sepsis and septic shock and complete within 3 
hours:
• Obtain blood culture specimens before antibiotic 
administration.
• Obtain serum lactate level.
• Administer broad-spectrum antibiotic (don’t 
delay more than 45 min for blood cultures).
• Initiate 30 mL/kg isotonic crystalloid fluids for 
hypotension or lactate level of 4 mmol/L or 
greater (may use albumin as part of initial fluid 
resuscitation in patients requiring substantial 
amounts of crystalloids; avoid hydroxyethyl 
starches).
• Goals are to achieve a mean arterial pressure 
(MAP) of 65 mm Hg and urine output >0.5 mL/
kg/hr.
Within 6 hours of recognition of severe sepsis 
or septic shock:
• Infuse vasopressors (for hypotension that 
doesn’t respond to initial fluid resuscitation or 
for abnormally low diastolic blood pressure) to 
maintain MAP of 65 mm Hg or greater. Intravenous 
norepinephrine is the vasopressor of choice.
• In the event of persistent arterial hypotension 
despite volume resuscitation (septic shock) or 
initial lactate of 4 mmol/L or more, measure CVP 
and aim for a target of 8-12 mm Hg; measure 
ScvO2 and target ScvO2 or SvO2 >70% or 
65%,respectively.
•	 Re-measure	lactate	if	initial	level	was	elevated.
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Two recent trials have challenged the effectiveness 
of SSC recommendations. The preliminary results of 
the Australasian Resuscitation in Sepsis Evaluation 
(ARISE) trial were released at the European Society 
of Intensive Care Medicine (ESICM) annual meeting 
in Barcelona in September 2014 and failed to show 
benefit of early goal-directed therapy. The results of 
this trial came within a year after the Protocolized 
Care for Early Septic Shock (ProCESS) trial released 
similar findings.35
Based on the conclusions of the ProCESS and 
ARISE trials, the SSC Executive Committee issued 
the following statement;
• Central venous pressure (CVP) and central venous 
oxygen saturation (ScvO2) monitoring as part of 
an early resuscitation strategy does not confer 
survival benefit in patients with septic shock who 
received timely antibiotics and fluid resuscitation 
compared with controls. 
• CVP and ScvO2 monitoring in all patients who 
have lactate levels >4 mmol/L and/or persistent 
hypotension after initial fluid challenge and who 
have received timely antibiotics is not supported 
by robust scientific evidence. 
• Results of the ProCESS and ARISE trials did not 
demonstrate adverse outcome in the group 
that utilized CVP and ScvO2 as end points for 
resuscitation. 
• In light of the evidence from the ProCESS and 
ARISE trials, the SSC guidelines committee will 
review the evidence and re-assess the guidelines 
and if required issue a focused update. 
• The current SSC bundles will not change till such 
time that the new guidelines are introduced.
•  When revised bundles become available, they will 
be posted on the SSC website and the SSC data 
collection tool will be modified appropriately. 
• The 3-hour SSC bundle will not be affected by 
this process.
Till SSC issues a focused update, management of 
the pregnant septic patients should continue as per 
the SSC recommendation, specially the first three 
hours bundle.
Hand hygiene and intravaginal application of 
antiseptics are the two main strategies described in 
the current literature to prevent puerperal sepsis, in 
addition to the prophylactic use of antibiotics during 
elective and emergency caesarian sections.36
MATERNAL RESUSCITATION
If cardiac arrest happens in a pregnant woman after 
20 weeks gestation, manual displacement of the 
uterus prevents aortocaval compression, increases 
venous return, cardiac output and uteroplacental 
perfusion. 
If initial resuscitation fails to revive the mother 
following a cardiac arrest and the foetus is of 
greater than 24 weeks gestation, emergency 
caesarian section to deliver the foetus within 5 
minutes of cardiac arrest facilitates maternal and 
foetal survival. 
Therapeutic hypothermia for 12-24 hours may be 
considered after return of spontaneous circulation 
to improve neurological outcome.33
CONCLUSIONS
Sepsis remains a leading cause of preventable 
maternal death in both developed and developing 
countries. Early recognition of the severity of an 
infection and effective maternal resuscitation by a 
multidisciplinary team of intensivists, anesthetists, 
neonatologists, obstetrician, midwives and 
pharmacists according to the standards set for 
delivering maternal critical care is the cornerstone 
for maternal and foetal wellbeing. 
KEY POINTS:
• Avoid aortocaval compression after 20 weeks of 
gestation by maintaining a lateral maternal tilt
• Monitor modified early obstetric warning score 
(MEOWS) for early recognition of critical illness 
in the obstetric population. early signs
• Implement resuscitation bundle within 3 hours 
of suspicion of maternal sepsis.
• Consider thromboprophylaxis early 
• Consider antenatal steroids if preterm delivery 
anticipated
• Do not neglect perineal and breast care while 
managing the critically ill mother in the in the 
intensive care unit
• Involve the pharmacist to prescribe drugs that 
pose less risk to the fetus during pregnancy, are 
safe if breast feeding and ensure appropriate 
dosing.
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